CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C06104 | BRD-K11883928 | BRD-K11883928 | -- | -- | -- | Details |
| C06105 | BRD-K11889659 | SA-441145 | -- | -- | -- | Details |
| C06106 | BRD-K11893906 | BRD-K11893906 | -- | -- | -- | Details |
| C06107 | BRD-K11901011 | BRD-K11901011 | -- | -- | -- | Details |
| C06108 | BRD-K11901207 | BRD-K11901207 | -- | -- | -- | Details |
| C06109 | BRD-K11903927 | vinylidene-chloride | -- | -- | -- | Details |
| C06110 | BRD-K11905747 | spectinomycin | -- | -- | -- | Details |
| C06111 | BRD-K11905754 | BRD-K11905754 | -- | -- | -- | Details |
| C06112 | BRD-K11911061 | GR-127935 | HTR1A; HTR1B; HTR1D; HTR2A; HTR2C | Serotonin receptor antagonist | -- | Details |
| C06113 | BRD-K11911738 | BRD-K11911738 | -- | -- | -- | Details |
| C06114 | BRD-K11913456 | BRD-K11913456 | -- | -- | -- | Details |
| C06115 | BRD-K11914584 | BRD-K11914584 | -- | -- | -- | Details |
| C06116 | BRD-K11923178 | BRD-K11923178 | -- | -- | -- | Details |
| C06117 | BRD-K11925125 | BRD-K11925125 | -- | -- | -- | Details |
| C06118 | BRD-K11927976 | ER-27319 | SYK | Syk inhibitor; Mediator release inhibitor | -- | Details |
| C06119 | BRD-K11928012 | BRD-K11928012 | -- | -- | -- | Details |
| C06120 | BRD-K11930946 | BRD-K11930946 | -- | -- | -- | Details |
| C06121 | BRD-K11932360 | BRD-K11932360 | -- | -- | -- | Details |
| C06122 | BRD-K11942486 | BRD-K11942486 | -- | -- | -- | Details |
| C06123 | BRD-K11943259 | BRD-K11943259 | -- | -- | -- | Details |
| C06124 | BRD-K11957311 | BRD-K11957311 | -- | -- | -- | Details |
| C06125 | BRD-K11957915 | BRD-K11957915 | -- | -- | -- | Details |
| C06126 | BRD-K11970601 | BRD-K11970601 | -- | -- | -- | Details |
| C06127 | BRD-K11973162 | tipiracil | TYMP | Thymidine phosphorylase inhibitor | -- | Details |
| C06128 | BRD-K11976754 | BRD-K11976754 | -- | -- | -- | Details |
| C06129 | BRD-K11977286 | BRD-K11977286 | -- | -- | -- | Details |
| C06130 | BRD-K11979048 | BRD-K11979048 | -- | -- | -- | Details |
| C06131 | BRD-K11981252 | BRD-K11981252 | -- | -- | -- | Details |
| C06132 | BRD-K11987248 | BRD-K11987248 | -- | -- | -- | Details |
| C06133 | BRD-K11987803 | BRD-K11987803 | -- | -- | -- | Details |
| C06134 | BRD-K11989341 | BRD-K11989341 | -- | -- | -- | Details |
| C06135 | BRD-K11989708 | SA-426029 | -- | -- | -- | Details |
| C06136 | BRD-K11990377 | BRD-K11990377 | -- | -- | -- | Details |
| C06137 | BRD-K12002134 | megestrol | -- | -- | -- | Details |
| C06138 | BRD-K12003101 | BRD-K12003101 | -- | -- | -- | Details |
| C06139 | BRD-K12011077 | BRD-K12011077 | -- | -- | -- | Details |
| C06140 | BRD-K12012973 | BRD-K12012973 | -- | -- | -- | Details |
| C06141 | BRD-K12015168 | BRD-K12015168 | -- | -- | -- | Details |
| C06142 | BRD-K12016928 | BRD-K12016928 | -- | -- | -- | Details |
| C06143 | BRD-K12017137 | BRD-K12017137 | -- | -- | -- | Details |
| C06144 | BRD-K12019169 | BRD-K12019169 | -- | -- | -- | Details |
| C06145 | BRD-K12025316 | BRD-K12025316 | -- | -- | -- | Details |
| C06146 | BRD-K12027235 | BRD-K12027235 | -- | -- | -- | Details |
| C06147 | BRD-K12034365 | BRD-K12034365 | -- | -- | -- | Details |
| C06148 | BRD-K12035825 | BRD-K12035825 | -- | -- | -- | Details |
| C06149 | BRD-K12040459 | AT-7867 | -- | -- | -- | Details |
| C06150 | BRD-K12043227 | BRD-K12043227 | -- | -- | -- | Details |
| C06151 | BRD-K12057275 | BRD-K12057275 | -- | -- | -- | Details |
| C06152 | BRD-K12057390 | apigenin | -- | -- | -- | Details |
| C06153 | BRD-K12064774 | BRD-K12064774 | -- | -- | -- | Details |
| C06154 | BRD-K12067186 | BRD-K12067186 | -- | -- | -- | Details |
| C06155 | BRD-K12067499 | BRD-K12067499 | -- | -- | -- | Details |
| C06156 | BRD-K12077693 | BRD-K12077693 | -- | -- | -- | Details |
| C06157 | BRD-K12079898 | PD-160170 | NPY1R | Neuropeptide receptor antagonist | -- | Details |
| C06158 | BRD-K12087429 | BRD-K12087429 | -- | -- | -- | Details |
| C06159 | BRD-K12089436 | BRD-K12089436 | -- | -- | -- | Details |
| C06160 | BRD-K12089955 | BRD-K12089955 | -- | -- | -- | Details |
| C06161 | BRD-K12091863 | BRD-K12091863 | -- | -- | -- | Details |
| C06162 | BRD-K12092185 | BRD-K12092185 | -- | -- | -- | Details |
| C06163 | BRD-K12097074 | BRD-K12097074 | -- | -- | -- | Details |
| C06164 | BRD-K12099407 | BRD-K12099407 | -- | -- | -- | Details |
| C06165 | BRD-K12102668 | nialamide | -- | -- | -- | Details |
| C06166 | BRD-K12105018 | BRD-K12105018 | -- | -- | -- | Details |
| C06167 | BRD-K12106308 | K-145 | -- | -- | -- | Details |
| C06168 | BRD-K12106433 | BRD-K12106433 | -- | -- | -- | Details |
| C06169 | BRD-K12107215 | BRD-K12107215 | -- | -- | -- | Details |
| C06170 | BRD-K12107322 | BRD-K12107322 | -- | -- | -- | Details |
| C06171 | BRD-K12107412 | BRD-K12107412 | -- | -- | -- | Details |
| C06172 | BRD-K12108140 | BRD-K12108140 | -- | -- | -- | Details |
| C06173 | BRD-K12111274 | BRD-K12111274 | -- | -- | -- | Details |
| C06174 | BRD-K12115687 | BRD-K12115687 | -- | -- | -- | Details |
| C06175 | BRD-K12117859 | BRD-K12117859 | -- | -- | -- | Details |
| C06176 | BRD-K12119989 | BRD-K12119989 | -- | -- | -- | Details |
| C06177 | BRD-K12120581 | BRD-K12120581 | -- | -- | -- | Details |
| C06178 | BRD-K12120659 | GR-144053 | ITGB3 | Integrin inhibitor | -- | Details |
| C06179 | BRD-K12124649 | BRD-K12124649 | -- | -- | -- | Details |
| C06180 | BRD-K12126940 | BRD-K12126940 | -- | -- | -- | Details |
| C06181 | BRD-K12132598 | BRD-K12132598 | -- | -- | -- | Details |
| C06182 | BRD-K12132610 | BRD-K12132610 | -- | -- | -- | Details |
| C06183 | BRD-K12145385 | BRD-K12145385 | -- | -- | -- | Details |
| C06184 | BRD-K12148366 | BRD-K12148366 | -- | -- | -- | Details |
| C06185 | BRD-K12159290 | BRD-K12159290 | -- | -- | -- | Details |
| C06186 | BRD-K12163240 | BRD-K12163240 | -- | -- | -- | Details |
| C06187 | BRD-K12165191 | BRD-K12165191 | -- | -- | -- | Details |
| C06188 | BRD-K12168891 | BRD-K12168891 | -- | -- | -- | Details |
| C06189 | BRD-K12175788 | BRD-K12175788 | -- | -- | -- | Details |
| C06190 | BRD-K12177722 | BRD-K12177722 | -- | -- | -- | Details |
| C06191 | BRD-K12181036 | BRD-K12181036 | -- | -- | -- | Details |
| C06192 | BRD-K12182524 | BRD-K12182524 | -- | -- | -- | Details |
| C06193 | BRD-K12184470 | flunarizine | CACNA1H; CACNA1G | Calcium channel blocker | -- | Details |
| C06194 | BRD-K12184916 | NVP-BEZ235 | MTOR; PIK3CA; PIK3CD; PIK3CG | MTOR inhibitor; PI3K inhibitor | dactolisib | Details |
| C06195 | BRD-K12187358 | BRD-K12187358 | -- | -- | -- | Details |
| C06196 | BRD-K12189280 | BRD-K12189280 | -- | -- | -- | Details |
| C06197 | BRD-K12202458 | BRD-K12202458 | -- | -- | -- | Details |
| C06198 | BRD-K12216461 | BRD-K12216461 | -- | -- | -- | Details |
| C06199 | BRD-K12219985 | glipizide | KCNJ11; ABCC8 | Sulfonylurea | -- | Details |
| C06200 | BRD-K12223973 | BRD-K12223973 | -- | -- | -- | Details |
| C06201 | BRD-K12226398 | BRD-K12226398 | -- | -- | -- | Details |
| C06202 | BRD-K12227848 | BRD-K12227848 | -- | -- | -- | Details |
| C06203 | BRD-K12230293 | BRD-K12230293 | -- | -- | -- | Details |